HUP0201687A3 - Oral administration form for administering a fixed tramadol and diclofenac combination - Google Patents

Oral administration form for administering a fixed tramadol and diclofenac combination

Info

Publication number
HUP0201687A3
HUP0201687A3 HU0201687A HUP0201687A HUP0201687A3 HU P0201687 A3 HUP0201687 A3 HU P0201687A3 HU 0201687 A HU0201687 A HU 0201687A HU P0201687 A HUP0201687 A HU P0201687A HU P0201687 A3 HUP0201687 A3 HU P0201687A3
Authority
HU
Hungary
Prior art keywords
tramadol
administering
fixed
oral administration
administration form
Prior art date
Application number
HU0201687A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7911586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0201687(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HUP0201687A2 publication Critical patent/HUP0201687A2/hu
Publication of HUP0201687A3 publication Critical patent/HUP0201687A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HU0201687A 1999-06-17 2000-06-13 Oral administration form for administering a fixed tramadol and diclofenac combination HUP0201687A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19927689A DE19927689A1 (de) 1999-06-17 1999-06-17 Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac

Publications (2)

Publication Number Publication Date
HUP0201687A2 HUP0201687A2 (en) 2002-09-28
HUP0201687A3 true HUP0201687A3 (en) 2005-07-28

Family

ID=7911586

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201687A HUP0201687A3 (en) 1999-06-17 2000-06-13 Oral administration form for administering a fixed tramadol and diclofenac combination

Country Status (15)

Country Link
US (1) US20020156133A1 (enExample)
EP (1) EP1185253B1 (enExample)
JP (1) JP4889897B2 (enExample)
AT (1) ATE260650T1 (enExample)
AU (1) AU778151B2 (enExample)
CA (1) CA2377174C (enExample)
DE (2) DE19927689A1 (enExample)
DK (1) DK1185253T3 (enExample)
ES (1) ES2215680T3 (enExample)
HK (1) HK1045113A1 (enExample)
HU (1) HUP0201687A3 (enExample)
MX (1) MXPA01013046A (enExample)
NZ (1) NZ516593A (enExample)
PT (1) PT1185253E (enExample)
WO (1) WO2000078294A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
US20030134810A1 (en) * 2001-10-09 2003-07-17 Chris Springate Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
EP1364649A1 (en) * 2002-05-23 2003-11-26 Cilag AG Adduct of topiramate and tramadol hydrochioride and uses thereof
EP1628685B1 (en) 2003-04-25 2010-12-08 Gilead Sciences, Inc. Antiviral phosphonate analogs
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
WO2006110157A2 (en) 2004-07-27 2006-10-19 Gilead Sciences, Inc. Nucleoside phosphonate conjugates as anti hiv agents
CN101257894A (zh) 2005-07-07 2008-09-03 法纳姆公司 高水溶性药物的缓释药物组合物
US20070009591A1 (en) * 2005-07-07 2007-01-11 Trivedi Jay S ACE inhibitor formulation
EP1785412A1 (en) * 2005-11-14 2007-05-16 IPCA Laboratories Limited Tramadol recovery process
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
DK2018160T3 (da) 2006-03-16 2012-02-06 Tris Pharma Inc Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
JP2008208078A (ja) * 2007-02-27 2008-09-11 Takada Seiyaku Kk 分割錠剤
HRP20120700T1 (hr) 2008-07-08 2012-09-30 Gilead Sciences SOLI SPOJEVA INHIBITORA HIV-a
DE102008056312A1 (de) 2008-11-07 2010-05-12 Biogenerics Pharma Gmbh Verwendung von Mikrotabletten als Lebens-und Futtermittelzusatz
KR20130129070A (ko) * 2010-07-12 2013-11-27 융신 파마슈티칼 인더스트리얼 컴파니 리미티드 트라마돌의 디클로페낙 염
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
ES2892402T3 (es) 2017-08-01 2022-02-04 Gilead Sciences Inc Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
CN110755396B (zh) * 2019-12-06 2022-04-08 北京悦康科创医药科技股份有限公司 一种布洛芬缓释小丸及其制备方法
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
DE3627423A1 (de) * 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5919826A (en) * 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel

Also Published As

Publication number Publication date
NZ516593A (en) 2003-08-29
ATE260650T1 (de) 2004-03-15
CA2377174C (en) 2009-07-28
EP1185253B1 (de) 2004-03-03
DE19927689A1 (de) 2000-12-21
DE50005529D1 (de) 2004-04-08
ES2215680T3 (es) 2004-10-16
WO2000078294A2 (de) 2000-12-28
WO2000078294A3 (de) 2001-03-29
AU778151B2 (en) 2004-11-18
MXPA01013046A (es) 2002-06-04
CA2377174A1 (en) 2000-12-28
PT1185253E (pt) 2004-07-30
DK1185253T3 (da) 2004-04-05
JP2003502360A (ja) 2003-01-21
US20020156133A1 (en) 2002-10-24
HUP0201687A2 (en) 2002-09-28
JP4889897B2 (ja) 2012-03-07
HK1045113A1 (zh) 2002-11-15
AU5680500A (en) 2001-01-09
EP1185253A2 (de) 2002-03-13

Similar Documents

Publication Publication Date Title
HUP0201687A3 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
HUP0201686A2 (en) Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
IL148407A0 (en) Oral pharmaceutical forms of administration with a delayed action
ZA9811239B (en) Oral pharmaceutical extended release dosage form
IL145581A0 (en) A modified release pharmaceutical composition comprising amoxycillin
EP1091732A4 (en) ORAL EFFERVESCENT MEDICATION DELIVERY SYSTEM
GB2351272B (en) Oral medicine dispenser
PL342515A1 (en) Drug administering device
IL113456A0 (en) Modified amino acids for oral drug delivery
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
NZ513700A (en) Oral drug delivery system
GR3036382T3 (en) Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
GB2355656B (en) Pharmaceutical compositions for oral and topical administration
EP1207852A4 (en) ORAL PHARMACEUTICALS WITH TAXED RELEASE FOR ORAL ADMINISTRATION
IL161143A0 (en) A flash-melt pharmaceutical oral dosage composition
HUP0102191A3 (en) Use of oxazolidinones for the preparation of a medicament for transdermal delivery
SI1185253T1 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
PL325509A1 (en) Therapeutic agent for oral administration
EP1210935A4 (en) DRUGS FOR ORAL USE
GB0018781D0 (en) A therapeutic chair
EP1188440A4 (en) MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION
SI1207867T1 (sl) Retardirane oralne farmacevtske dajalne oblike s tramadolom
SI1183015T1 (en) Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
HUP0101012A3 (en) Pharmaceutical composition for oral administration

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees